Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer

HIGHLIGHTS

• who: Baihua Zhang from the Beijing Cancer Hospital, Peking University, China have published the research work: Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer, in the Journal: (JOURNAL) of July/30,/2022
• what: The Ethics Committee of Hunan Cancer Hospital approved this study (No 2022097), and patients` written informed consent was obtained. This study showed that ESCC might achieve better therapeutic efficacy from nCIT and nCRT on the basis of pCR and MPR results.
• future: More prospective phase III clinical trials . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.